Tag

Briumvi

All articles tagged with #briumvi

TG Therapeutics Stock Plummets 50% on Disappointing Q2 Results

Originally Published 2 years ago — by Investor's Business Daily

TG Therapeutics' stock plunged by 49.3% after sales of its multiple sclerosis drug, Briumvi, fell short of analysts' expectations. Briumvi generated $16.1 million in U.S. sales during the second quarter, missing the forecasted $17.4 million. The drug faces competition from Roche's Ocrevus, which is being tested as an under-the-skin injection. TG Therapeutics also announced a deal with Neuraxpharm Group to commercialize Briumvi in Europe, but the stock hit an eight-month low following the news.

business business briumvi business multiple-sclerosis-drug roche sales tg-therapeutics

Advancements in MS Treatment and Technology: Ocrevus, Assistive Devices, and Virtual Reality.

Originally Published 2 years ago — by Multiple Sclerosis News Today

A study funded by Genentech found that early treatment with Ocrevus is better than later treatment for MS patients. Engineering and nursing students at the University of Detroit Mercy created new assistive devices for people with MS and other physical conditions. Virtual reality therapy may improve balance and reduce fear of falling for MS patients. Briumvi has been prescribed to over 400 MS patients since its approval last year and will receive a permanent J-code for billing and reimbursement purposes.

health health assistive-devices briumvi health ms ocrevus virtual-reality